Stellar Biotechnologies

The full company name is Edesa Biotech Inc.

Serve Robotics Inc

Revenue of $0.95 million; 124% sequential growth in delivery and branding revenue Signed agreement with Magna International for a long-term licensing partnership and exclusive contract manufacturing of Serve robots Post quarter-end, successfully uplisted to the Nasdaq Capital Market with concurrent $40 million equity offering Continued focus on deploying 2,000 robots under Uber Eats contract SAN FRANCISCO , May 15, 2024 /PRNewswire/ -- Serve Robotics Inc. (the "Company" or "Serve") (Nasdaq:SERV), a leading autonomous sidewalk delivery company, today announced financial results for the three months ended March 31, 2024 and provided a corporate update. "The Company delivered improvements in our operational key metrics and fundamentals, including a 97% increase in daily supply hours and a 70% increase in daily active robots, when compared to the first quarter of last year.

Serve Robotics Announces First Quarter 2024 Results and Provides Corporate Update

SAN FRANCISCO , March 7, 2024 /PRNewswire/ -- Serve Robotics Inc.  (the "Company" or "Serve"), a leading autonomous sidewalk delivery company, announces that it has qualified to trade on the OTCQB® Venture Market operated by the OTC Markets Group Inc. and the Company's common shares commenced trading today on the OTCQB under the ticker symbol "SBOT". "Serve's transition to a publicly traded entity marks an important moment in the robotics landscape, showcasing our role as one of the first to commercially deploy AI-powered robots in urban settings.

News for Stellar Biotechnologies Stock (SBOT)